Caliway Biopharmaceuticals
6919.TWO
16.20 USD
0.21
+1.31%
c
Overview
Last close
16.20 usd
Market cap
2.26B usd
52 week high
22.88 usd
52 week low
4.65 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2466.6267
Price/Book Value
23.4976
Enterprise Value
2.31B usd
EV/Revenue
2126.8119
EV/EBITDA
-102.5784
Key financials
Revenue TTM
1.09M usd
Gross Profit TTM
N/A usd
EBITDA TTM
-20.01M usd
Earnings per Share
-0.14 usd
Dividend
N/A usd
Total assets
N/A usd
Net debt
N/A usd
About
Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease. The company was founded in 2012 and is based in New Taipei City, Taiwan.
- Symbol6919.TWO
- ExchangeTWO
- IsinN/A
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CEOMs. Yufang Ling
- HeadquarterNew Taipei City
- Web sitehttps://www.caliway.com.tw
